{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:30:07Z","timestamp":1790512207788,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02131","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T08:48:11Z","timestamp":1568018891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Immunophenotype of a Rat Model of Duchenne's Disease and Demonstration of Improved Muscle Strength After Anti-CD45RC Antibody Treatment"],"prefix":"10.3389","volume":"10","author":[{"given":"Laure-H\u00e9l\u00e8ne","family":"Ouisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Lafoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chenouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Guillonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Vimond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Rouger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"P\u00e9r\u00e9on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Chenouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christ\u00e8le","family":"Gras-Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Braudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Josien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum Mol Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"FASEB J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nmd.2017.05.009","article-title":"Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents","volume":"27","author":"Robertson","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"299rv294","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci Transl Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/01.bpo.0000167368.17274.54","article-title":"Duchenne muscular dystrophy and steroids: pharmacologic treatment in the absence of effective gene therapy","volume":"25","author":"Alman","year":"2005","journal-title":"J Pediatr Orthop."},{"key":"B8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.4049\/jimmunol.153.10.4798","article-title":"Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy","volume":"153","author":"Gussoni","year":"1994","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/hum.2013.092","article-title":"Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect","volume":"24","author":"Flanigan","year":"2013","journal-title":"Hum Gene Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"258ra142","DOI":"10.1126\/scitranslmed.3009925","article-title":"Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy","volume":"6","author":"Villalta","year":"2014","journal-title":"Sci Transl Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3389\/fimmu.2017.02014","article-title":"Ex vivo expanded human non-cytotoxic CD8(+)CD45RC(low\/-) tregs efficiently delay skin graft rejection and GVHD in humanized mice","volume":"8","author":"Bezie","year":"2018","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e90088","DOI":"10.1172\/jci.insight.90088","article-title":"Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells","volume":"2","author":"Picarda","year":"2017","journal-title":"JCI Insight."},{"key":"B16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1096\/fj.12-219907","article-title":"Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases","volume":"27","author":"Menoret","year":"2013","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0119686","DOI":"10.1371\/journal.pone.0119686","article-title":"Fibrinogen-like protein 2\/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells","volume":"10","author":"Bezie","year":"2015","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1096\/fj.04-2511fje","article-title":"Prednisolone-induced changes in dystrophic skeletal muscle","volume":"19","author":"Fisher","year":"2005","journal-title":"FASEB J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD003725","DOI":"10.1002\/14651858.CD003725.pub4","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"5","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B20","author":"De Luca","year":"2008","journal-title":"Use of Grip Strength Meter to Assess the Limb Strength of mdx Mice."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0167707","DOI":"10.1371\/journal.pone.0167707","article-title":"Soluble milk protein supplementation with moderate physical activity improves locomotion function in aging rats","volume":"11","author":"Lafoux","year":"2016","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/jnc.13269","article-title":"Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy","volume":"136","author":"Zschuntzsch","year":"2016","journal-title":"J Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ebiom.2015.02.014","article-title":"Functional and morphological improvement of Dystrophic muscle by interleukin 6 receptor blockade","volume":"2","author":"Pelosi","year":"2015","journal-title":"EBioMedicine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-7-1","article-title":"Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice","volume":"7","author":"Swiderski","year":"2014","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B26","doi-asserted-by":"publisher","first-page":"17784","DOI":"10.1074\/jbc.M115.655019","article-title":"Sulforaphane attenuates muscle inflammation in Dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated Inhibition of NF-kappaB signaling pathway","volume":"290","author":"Sun","year":"2015","journal-title":"J Biol Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0155944","DOI":"10.1371\/journal.pone.0155944","article-title":"Effect of the IL-1 receptor antagonist kineret(R) on disease phenotype in mdx mice","volume":"11","author":"Benny Klimek","year":"2016","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.pmrj.2009.04.010","article-title":"Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention","volume":"1","author":"Evans","year":"2009","journal-title":"PM R."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2006.03.005","article-title":"Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy","volume":"175","author":"Andreetta","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/TP.0000000000002258","article-title":"Advances on CD8+ Tregs and their potential in transplantation","volume":"102","author":"Bezie","year":"2018","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cmet.2015.03.005","article-title":"Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice","volume":"21","author":"Kolodin","year":"2015","journal-title":"Cell Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1084\/jem.20040912","article-title":"An anti-CD45RO\/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells","volume":"201","author":"Gregori","year":"2005","journal-title":"J Exp Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/380717a0","article-title":"Prevention and reversal of renal allograft rejection by antibody against CD45RB","volume":"380","author":"Lazarovits","year":"1996","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin Immunol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/407023","article-title":"Immunological characterization of a rat model of Duchenne's disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment","volume":"407023","author":"Ouisse","year":"2018","journal-title":"bioRxiv."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:24:13Z","timestamp":1695158653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2019.02131"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02131","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/407023","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"article-number":"2131"}}